NMTR / 9 Meters Biopharma Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

9 Meters Biopharma Inc
US ˙ NASDAQ ˙ US6544051096
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

Ações de Insider15,953,350 shares
Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Veja as Ações de Maior Classificação
Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Veja as Ações de Maior Classificação
Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

N/A

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

N/A

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

9 Meters Biopharma Inc negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider Lucro Médio (%) Ações
Possuídas		 Ajuste
de Divisão

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em NMTR / 9 Meters Biopharma Inc. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custo Dias até
Máx		 Preço em
Máx		 Lucro
Máximo ($)		 Retorno Máximo (%)
2022-07-06 Temperato John 125,000 0.2277 6,250 4.5540 28,462 50 6.3 10,913 38.34
2022-07-01 Sirgo Mark A 175,000 0.2455 8,750 4.9100 42,962
2022-05-23 Constantino Michael T. 16,000 0.4755 800 9.5100 7,608
2022-05-18 Sirgo Mark A 106,383 0.4700 5,319 9.4000 50,000
2022-05-18 Temperato John 50,000 0.4457 2,500 8.9140 22,285
2022-03-03 Temperato John 100,000 0.5559 5,000 11.1180 55,590
2022-03-03 Sirgo Mark A 86,450 0.5784 4,322 11.5680 50,002
2021-12-02 Sirgo Mark A 50,000 0.8900 2,500 17.8000 44,500
2021-11-18 Sirgo Mark A 20,000 1.0600 1,000 21.2000 21,200

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

NMTR / 9 Meters Biopharma Inc Insider Trades
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em NMTR / 9 Meters Biopharma Inc. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custo Dias até
Mín		 Preço em
Mín		 Máxima Perda
Evitada ($)		 Máxima Perda
Evitada (%)
2023-04-21 Sensenig Bethany 9,100 1.2100 9,100 1.2100 11,011 95 0.0722 -10,354 -94.03
2021-06-25 OrbiMed Israel GP Ltd. 15,989,876 1.2100 799,494 24.2000 19,347,750
2021-06-24 OrbiMed Israel GP Ltd. 319,255 1.3800 15,963 27.6000 440,572
2021-06-23 OrbiMed Israel GP Ltd. 841,650 1.3600 42,082 27.2000 1,144,644

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

NMTR / 9 Meters Biopharma Inc Insider Trades
Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo
Data		 Data da
Operação		 Formulário Insider Ticker Título de Segurança Código 10b5-1 Direto Preço de Exercício
Preço Unitário		 Preço por
Unidade		 Unidades
Alteradas		 Valor
Alterado (1K)		 Opções
Restantes		 Ações
Restantes
2023-04-21 2023-04-21 4 Sensenig Bethany NMTR Common stock S - Sale D 1.2100 -9,100 -11 41,077
2023-03-31 2023-03-29 4 Sirgo Mark A NMTR Common Stock A - Award D 7,885 85,907
2023-03-31 2023-03-29 4 RICE YEHUDA MICHAEL NMTR Common Stock A - Award D 7,885 7,885
2023-03-31 2023-03-29 4 JOHNSON LORIN K NMTR Common Stock A - Award D 7,885 12,125
2023-03-31 2023-03-29 4 Constantino Michael T. NMTR Common Stock A - Award D 7,885 10,911
2023-03-31 2023-03-29 4 Ventimiglia Samantha NMTR Common Stock A - Award D 7,885 7,885
2023-03-29 2023-03-27 4 Temperato John NMTR Common Stock A - Award D 68,815 140,192
2023-03-29 2023-03-27 4 Sensenig Bethany NMTR Common Stock A - Award D 50,177 50,177
2022-07-22 2022-07-01 4/A Sirgo Mark A NMTR Common stock A - Award D 0.2455 175,000 43 1,560,428
2022-07-08 2022-07-06 4 Temperato John NMTR Common stock P - Purchase D 0.2277 125,000 28 1,427,522
2022-07-06 2022-07-01 4 Sirgo Mark A NMTR Common stock P - Purchase D 0.2455 175,000 43 1,454,045
2022-05-24 2022-05-23 4 Constantino Michael T. NMTR Common Stock P - Purchase D 0.4755 16,000 8 60,509
2022-05-19 2022-05-18 4 Temperato John NMTR Common Stock P - Purchase D 0.4457 50,000 22 1,302,522
2022-05-19 2022-05-18 4 Sirgo Mark A NMTR Common Stock P - Purchase D 0.4700 106,383 50 1,385,428
2022-03-21 2020-08-20 4/A Constantino Michael T. NMTR Common stock P - Purchase D 0.7545 26,509 20 26,509
2022-03-07 2022-03-03 4 Sirgo Mark A NMTR Common stock P - Purchase D 0.5784 86,450 50 1,279,045
2022-03-04 2022-03-03 4 Temperato John NMTR Common stock P - Purchase D 0.5559 100,000 56 1,252,522
2022-02-23 2022-02-21 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0.65 2,479,060 2,479,060
2022-01-18 2022-01-18 4 Sensenig Bethany NMTR Stock Option (Right to Buy) A - Award D 0.84 1,300,000 1,300,000
2021-12-03 2021-12-02 4 Sirgo Mark A NMTR Common Stock P - Purchase D 0.8900 50,000 44 1,242,595
2021-11-22 2021-11-18 4 Sirgo Mark A NMTR Common stock P - Purchase D 1.0600 20,000 21 1,192,595
2021-11-19 2021-11-18 4 Temperato John NMTR Common stock P - Purchase D 1.0500 50,000 52 1,152,522
2021-10-04 2021-10-01 4 Ventimiglia Samantha NMTR Stock Option (Right to Buy) A - Award D 1.29 1.2900 150,000 194 150,000
2021-09-15 2021-09-14 4 Sitar Edward J NMTR Common stock P - Purchase D 1.2200 15,000 18 194,338
2021-09-08 2021-09-07 4 Sirgo Mark A NMTR Common stock P - Purchase D 1.3600 73,529 100 1,172,595
2021-08-26 2021-08-24 4 Constantino Michael T. NMTR Common stock P - Purchase D 1.1400 18,000 21 52,108
2021-08-23 2021-08-20 4 Sirgo Mark A NMTR Common stock P - Purchase D 1.1000 25,000 28 1,099,066
2021-08-19 2021-08-18 4 Temperato John NMTR Common stock P - Purchase D 1.0500 25,000 26 1,102,522
2021-06-25 2021-06-25 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock S - Sale I 1.2100 -15,989,876 -19,348 8,565,974
2021-06-25 2021-06-24 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock S - Sale I 1.3800 -319,255 -441 24,555,850
2021-06-25 2021-06-23 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock S - Sale I 1.3600 -841,650 -1,145 24,875,105
2021-06-23 2021-06-22 4 JOHNSON LORIN K NMTR Stock Option (Right to Buy) A - Award D 1.38 90,000 90,000
2021-06-23 2021-06-22 4 Sirgo Mark A NMTR Stock Option (Right to Buy) A - Award D 1.38 90,000 90,000
2021-06-23 2021-06-22 4 Constantino Michael T. NMTR Stock Option (Right to Buy) A - Award D 1.38 90,000 90,000
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Stock Option (right to buy) X - Other I 0.62 19,444 80,556
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Stock Option (right to buy) X - Other I 0.70 12,500 37,500
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes (1)(2 NMTR Common Stock X - Other I 0.6216 19,444 12 25,748,699
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock X - Other I 0.7000 12,500 9 25,729,255
2021-04-06 2021-04-05 4 Sirgo Mark A NMTR Common stock P - Purchase D 1.0000 300,000 300 1,074,066
2021-04-06 2021-04-05 4 Temperato John NMTR Common stock P - Purchase D 1.0000 100,000 100 1,077,522
2021-04-06 2021-04-05 4 Sitar Edward J NMTR Common stock P - Purchase D 1.0000 50,000 50 179,338
2021-03-19 2020-05-04 4/A OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock P - Purchase I 67,865 6,786,500
2021-03-19 2020-05-04 4/A OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock P - Purchase I 67,865 6,786,500
2021-03-19 2020-04-30 4/A OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock A - Award I 18,930,255 18,930,255
2021-03-02 2021-02-26 4 RICE YEHUDA MICHAEL NMTR Stock Option (Right to Buy) A - Award D 1.66 150,000 150,000
2021-02-05 2021-02-04 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 1.81 1,309,626 1,309,626
2021-02-05 2021-02-04 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 1.81 477,468 477,468
2020-12-17 2020-12-15 4 Sirgo Mark A NMTR Common stock P - Purchase D 0.6500 230,769 150 774,066
2020-12-17 2020-12-15 4 Temperato John NMTR Common stock P - Purchase D 0.6500 153,846 100 977,522
2020-12-17 2020-12-15 4 Sitar Edward J NMTR Common stock P - Purchase D 0.6500 61,538 40 129,338
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 1.07 639,655 639,655
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 1.07 650,000 650,000
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 0.62 -639,655 310,345
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 0.62 -650,000 0
2020-12-01 2020-11-27 4 Temperato John NMTR Common stock A - Award D 203,667 823,676
2020-11-03 2020-10-30 4 OrbiMed Israel GP Ltd. NMTR Common stock J - Other I 1,943,734 25,716,755
2020-11-03 2020-10-30 4 Sirgo Mark A NMTR Common stock J - Other D 4,513 543,297
2020-11-03 2020-10-30 4 Darvish Nissim NMTR Common stock J - Other I 1,943,734 25,716,755
2020-11-03 2020-10-30 4 Temperato John NMTR Common stock J - Other D 4,513 620,009
2020-09-14 2020-09-11 4 Sirgo Mark A by spouse NMTR Common stock P - Purchase I 0.6518 21,485 14 21,485
2020-09-14 2020-09-11 4 Sirgo Mark A NMTR Common stock P - Purchase D 0.6800 77,000 52 538,784
2020-09-14 2020-09-10 4 Sirgo Mark A NMTR Common stock P - Purchase D 0.6000 50,000 30 461,784
2020-08-24 2020-08-21 4 Temperato John NMTR Common stock P - Purchase D 0.6900 70,000 48 615,496
2020-08-21 2020-08-20 4 Constantino Michael T. NMTR Common stock P - Purchase D 0.7500 34,108 26 34,108
2020-08-18 2020-08-17 4 Sirgo Mark A NMTR Common stock P - Purchase D 0.5600 100,000 56 411,784
2020-08-17 2020-08-17 4 Temperato John NMTR Common stock P - Purchase D 0.5666 35,000 20 545,496
2020-07-08 2020-07-06 4 Constantino Michael T. NMTR Stock Option (Right to Buy) A - Award D 0.62 150,000 150,000
2020-07-08 2020-07-06 4 Darvish Nissim NMTR Stock Option (Right to Buy) A - Award I 0.62 100,000 100,000
2020-07-08 2020-07-06 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0.62 225,000 775,000
2020-07-08 2020-07-06 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0.62 550,000 550,000
2020-07-08 2020-07-06 4 JOHNSON LORIN K NMTR Stock Option (Right to Buy) A - Award D 0.62 150,000 150,000
2020-07-08 2020-07-06 4 Laumas Sandeep NMTR Stock Option (Right to Buy) A - Award D 0.62 150,000 150,000
2020-07-08 2020-07-06 4 Sirgo Mark A NMTR Stock Option (Right to Buy) A - Award D 0.62 100,000 100,000
2020-07-08 2020-07-06 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0.62 650,000 1,600,000
2020-07-08 2020-07-06 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0.62 950,000 950,000
2020-07-02 2020-06-30 4 Darvish Nissim NMTR Series A Convertible Preferred Stock C - Conversion I -67,865 0
2020-07-02 2020-06-30 4 Darvish Nissim See footnote 1 NMTR Common stock C - Conversion I 6,786,500 23,773,021
2020-07-02 2020-06-30 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock C - Conversion I -67,865 0
2020-07-02 2020-06-30 4 OrbiMed Israel GP Ltd. NMTR Common stock C - Conversion I 6,786,500 23,773,021
2020-07-02 2020-06-30 4 Sitar Edward J NMTR Series A Convertible Preferred Stock C - Conversion D -678 0
2020-07-02 2020-06-30 4 Sitar Edward J NMTR Common stock C - Conversion D 67,800 67,800
2020-07-02 2020-06-30 4 Laumas Sandeep NMTR Series A Convertible Preferred Stock C - Conversion D -424 0
2020-07-02 2020-06-30 4 Laumas Sandeep NMTR Common stock C - Conversion D 42,400 60,400
2020-07-02 2020-06-30 4 Temperato John NMTR Series A Convertible Preferred Stock C - Conversion D -2,714 0
2020-07-02 2020-06-30 4 Temperato John NMTR Common stock C - Conversion D 271,400 510,496
2020-07-02 2020-06-30 4 JOHNSON LORIN K NMTR Series A Convertible Preferred Stock C - Conversion D -848 0
2020-07-02 2020-06-30 4 JOHNSON LORIN K NMTR Common stock C - Conversion D 84,800 84,800
2020-07-02 2020-06-30 4 Sirgo Mark A NMTR Series A Convertible Preferred Stock C - Conversion D -2,544 0
2020-07-02 2020-06-30 4 Sirgo Mark A NMTR Common stock C - Conversion D 254,400 311,784
2020-07-01 2020-06-30 4 Temperato John NMTR Common stock A - Award D 189,655 239,096
2020-06-16 2020-06-15 4 Sirgo Mark A NMTR Common stock P - Purchase D 0.5975 17,943 11 57,384
2020-06-15 2020-06-15 4 Temperato John NMTR Common stock P - Purchase D 0.5971 10,000 6 49,441
2020-05-05 2020-05-04 4 Darvish Nissim NMTR Series A Convertible Preferred Warrant P - Purchase I 67,865 6,786,500
2020-05-05 2020-05-04 4 Darvish Nissim NMTR Series A Convertible Preferred Stock P - Purchase I 67,865 6,786,500
2020-05-05 2020-05-04 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Warrant P - Purchase I 67,865 6,786,500
2020-05-05 2020-05-04 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock P - Purchase I 67,865 6,786,500
2020-05-04 2020-04-30 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0.70 1,000,000 1,000,000
2020-05-04 2020-05-04 4 Temperato John NMTR Series A Convertible Preferred Warrant P - Purchase D 2,714 271,400
2020-05-04 2020-05-04 4 Temperato John NMTR Series A Convertible Preferred Stock P - Purchase D 2,714 271,400
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33,973,042
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33,973,042
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33,973,042
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33,973,042
2020-05-04 2020-04-30 4 Sirgo Mark A NMTR Stock Option (Right to Buy) A - Award D 0.70 50,000 50,000
2020-05-04 2020-05-04 4 Sirgo Mark A NMTR Series A Convertible Preferred Warrant P - Purchase D 2,544 254,400
2020-05-04 2020-05-04 4 Sirgo Mark A NMTR Series A Convertible Preferred Stock P - Purchase D 2,544 254,400
2020-05-04 2020-04-30 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Stock Option (Right to Buy) A - Award I 0.70 50,000 50,000
2020-05-04 3 Darvish Nissim See footnote 1 NMTR Common stock I 33,973,042
2020-05-04 3 Darvish Nissim See footnote 1 NMTR Common stock I 33,973,042
2020-05-04 3 Darvish Nissim See footnote 1 NMTR Common stock I 33,973,042
2020-05-04 2020-04-30 4 Darvish Nissim NMTR Stock Option (Right to Buy) A - Award I 0.70 50,000 50,000
2020-05-04 3 Sirgo Mark A NMTR Common stock D 78,882
2020-05-04 3 Sirgo Mark A NMTR Common stock D 78,882
2020-05-04 3 Sirgo Mark A NMTR Common stock D 78,882
2020-05-04 3 Temperato John NMTR Common stock D 78,882
2020-05-04 3 Temperato John NMTR Common stock D 78,882
2020-05-04 3 Temperato John NMTR Common stock D 78,882
2020-05-04 2020-05-04 4 JOHNSON LORIN K NMTR Series A Convertible Preferred Warrant P - Purchase D 848 84,800
2020-05-04 2020-05-04 4 JOHNSON LORIN K NMTR Series A Convertible Preferred Stock P - Purchase D 848 84,800
2020-05-04 2020-05-04 4 Laumas Sandeep NMTR Series A Convertible Preferred Warrant P - Purchase D 424 42,400
2020-05-04 2020-05-04 4 Laumas Sandeep NMTR Series A Convertible Preferred Stock P - Purchase D 424 42,400
2020-05-04 2020-05-04 4 Sitar Edward J NMTR Series A Convertible Preferred Warrant P - Purchase D 678 67,800
2020-05-04 2020-05-04 4 Sitar Edward J NMTR Series A Convertible Preferred Stock P - Purchase D 678 67,800
2020-05-04 2020-04-24 4 Proujansky Roy NMTR Stock Option (Right to Buy) A - Award D 0.60 25,000 25,000
2020-05-04 2020-04-24 4 JOHNSON LORIN K NMTR Stock Option (Right to Buy) A - Award D 0.60 25,000 25,000
2020-05-04 2020-04-24 4 Laumas Sandeep NMTR Stock Option (Right to Buy) A - Award D 0.60 389,294 389,294
2020-05-04 2020-04-24 4 MAIDA ANTHONY E III NMTR Stock Option (Right to Buy) A - Award D 0.60 25,000 25,000
2020-05-04 2020-04-30 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0.70 125,000 125,000
2020-05-04 2020-04-24 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0.60 176,156 176,156
2020-05-04 2020-04-24 4 Madan Jay P. NMTR Stock Option (Right to Buy) A - Award D 0.60 203,406 203,406
2020-05-04 2020-04-24 4 Ramasastry Saira NMTR Stock Option (Right to Buy) A - Award D 0.60 25,000 25,000
2019-08-27 2019-08-20 4 Madan Jay P. INNT Stock Option (Right to Buy) A - Award D 0.89 200,000 200,000
2019-08-27 2019-08-20 4 Laumas Sandeep INNT Stock Option (Right to Buy) A - Award D 0.89 400,000 400,000
2019-07-03 2019-07-01 4 Sitar Edward J INNT Stock Option (Right to Buy) A - Award D 1.17 350,000 350,000
2019-07-01 2019-06-28 4 Laumas Sandeep INNT Common stock P - Purchase D 1.1500 4,000 5 18,000
2019-06-17 2019-06-13 4 Laumas Sandeep INNT Common stock P - Purchase D 1.2200 591 1 14,000
2019-06-17 2019-06-13 4 Laumas Sandeep INNT Common stock P - Purchase D 1.2100 409 0 13,409
2019-06-04 2019-05-31 4 JOHNSON LORIN K INNT Stock Option (Right to Buy) A - Award D 1.28 25,000 25,000
2019-06-04 2019-05-31 4 MAIDA ANTHONY E III INNT Stock Option (Right to Buy) A - Award D 1.28 25,000 25,000
2019-06-04 2019-05-31 4 Proujansky Roy INNT Stock Option (Right to Buy) A - Award D 1.28 25,000 25,000
2019-06-04 2019-05-31 4 Ramasastry Saira INNT Stock Option (Right to Buy) A - Award D 1.28 25,000 25,000
2019-06-03 2019-05-30 4 Madan Jay P. INNT Common stock P - Purchase D 1.3200 5,000 7 84,131
2019-05-28 2019-05-24 4 Proujansky Roy INNT Common stock P - Purchase D 1.2800 1,000 1 2,400
2019-05-23 2019-05-22 4 Laumas Sandeep INNT Common stock P - Purchase D 1.3800 5,000 7 13,000
2018-12-07 2018-12-04 4 Ramasastry Saira INNT Stock Option (Right to Buy) A - Award D 2.41 25,000 25,000
2018-12-07 2018-12-04 4 Ramasastry Saira INNT Stock Option (Right to Buy) A - Award D 6.94 50,000 50,000
2018-12-07 2018-12-04 4 Proujansky Roy INNT Stock Option (Right to Buy) A - Award D 2.41 25,000 25,000
2018-12-07 2018-12-04 4 Proujansky Roy INNT Stock Option (Right to Buy) A - Award D 6.94 50,000 50,000
2018-12-07 2018-12-04 4 JOHNSON LORIN K INNT Stock Option (Right to Buy) A - Award D 2.41 25,000 25,000
2018-12-07 2018-12-04 4 MAIDA ANTHONY E III INNT Stock Option (Right to Buy) A - Award D 2.41 25,000 25,000
2018-12-03 2018-11-30 4 Proujansky Roy INNT Common stock P - Purchase D 2.6300 1,400 4 1,400
2018-12-03 2018-11-30 4 Laumas Sandeep INNT Common stock P - Purchase D 2.6300 1,000 3 8,000
2018-12-03 2018-11-30 4 Laumas Sandeep INNT Common stock P - Purchase D 2.6200 1,000 3 7,000
2018-12-03 2018-11-30 4 Laumas Sandeep INNT Common stock P - Purchase D 2.6400 1,000 3 6,000
2018-11-29 2018-11-29 4 Prior Christopher P. INNT Common stock P - Purchase D 2.7500 5,000 14 7,009
2018-11-29 2018-11-29 4 Laumas Sandeep INNT Common stock P - Purchase D 2.5600 2,000 5 5,000
2018-11-29 2018-11-29 4 Laumas Sandeep INNT Common stock P - Purchase D 2.5500 1,000 3 3,000
2018-09-14 2018-09-14 4 Prior Christopher P. INNT Common stock P - Purchase D 5.8200 200 1 2,009
2018-09-13 2018-09-12 4 Prior Christopher P. INNT Common stock P - Purchase D 6.1300 500 3 1,809
2018-09-10 2018-09-07 4 Laumas Sandeep INNT Common stock P - Purchase D 6.1000 500 3 2,000
2018-08-30 2018-08-28 4/A Laumas Sandeep INNT Common stock P - Purchase D 4.9000 250 1 250
2018-08-30 2018-08-30 4 Prior Christopher P. INNT Common stock P - Purchase D 5.2000 309 2 1,309
2018-08-30 2018-08-30 4 Laumas Sandeep INNT Common stock P - Purchase D 5.2400 500 3 750
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 5.0800 405 2 1,000
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 5.0700 95 0 595
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 4.8800 250 1 500
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 4.9000 0 0 250
2018-08-28 2018-08-28 4 Prior Christopher P. INNT Common stock P - Purchase D 4.9300 1,000 5 1,000
2018-08-28 2018-08-27 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4.9400 100 0 900
2018-08-28 2018-08-27 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4.9600 253 1 800
2018-08-28 2018-08-27 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4.9000 47 0 547
2018-08-28 2018-08-24 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4.8500 500 2 1,400
2018-08-28 2018-08-24 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4.9900 400 2 500
2018-08-28 2018-08-24 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4.8500 100 0 100
2018-04-18 3 Sea Island Partnership LLC INNT Common Stock D 5,784,596
2018-04-18 3 Sea Island Partnership LLC INNT Common Stock D 5,784,596
2018-04-18 3 Sea Island Partnership LLC INNT Common Stock D 5,784,596
2018-04-18 3 Moonstar Family Partnership LLC INNT Common Stock D 5,376,434
2018-04-18 3 Moonstar Family Partnership LLC INNT Common Stock D 5,376,434
2018-04-18 3 Moonstar Family Partnership LLC INNT Common Stock D 5,376,434
2018-03-13 3 CLARKE DAVID H By GSB Holdings, Inc INNT Common Stock I 2,781,800
2018-03-13 3 CLARKE DAVID H INNT Common Stock D 2,373,550
2018-03-13 3 CLARKE DAVID H By GSB Holdings, Inc INNT Common Stock I 2,781,800
2018-03-13 3 CLARKE DAVID H INNT Common Stock D 2,373,550
2018-03-13 2018-01-25 4 CLARK JONATHAN P INNT Common Stock A - Award D 10,000 285,000
2018-03-13 2018-01-25 4 Olert David Lewis INNT Common Stock A - Award D 10,000 70,000
2018-03-13 2018-01-26 4 CLARKE DAVID H INNT Common Stock P - Purchase I 0.3500 300,000 105 1,718,450
2018-03-13 2018-01-25 4 CLARKE DAVID H INNT Common Stock A - Award D 25,000 1,418,450
2018-03-13 2018-01-24 4 CLARKE DAVID H INNT Common Stock A - Award I 17,746 1,393,450
2018-03-13 2017-11-29 4 CLARKE DAVID H INNT Common Stock P - Purchase I 0.4500 366,159 165 1,375,704
2018-03-13 2017-11-09 4 CLARKE DAVID H INNT Common Stock A - Award D 100,000 1,009,545
2018-03-13 2017-06-30 4 CLARKE DAVID H INNT Common Stock A - Award I 13,467 909,545
2018-03-13 2017-06-30 4 CLARKE DAVID H INNT Common Stock A - Award I 33,621 896,078
2018-03-13 2017-06-23 4 CLARKE DAVID H INNT Common Stock P - Purchase I 0.5800 172,414 100 862,457
2018-03-13 2017-03-16 4 CLARKE DAVID H INNT Common Stock P - Purchase I 1.5000 70,000 105 690,043
2018-03-13 2017-01-24 4 CLARKE DAVID H INNT Common Stock A - Award D 175,000 620,043
2018-03-13 2016-07-13 4 CLARKE DAVID H INNT Common Stock P - Purchase D 4.5000 15,000 68 445,043
2018-02-08 3 Laumas Sandeep INNT Common Stock I 1,516,746
2018-02-08 3 Laumas Sandeep INNT Common Stock I 1,516,746
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,154,629
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,147,140
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,147,140
2018-02-08 3 Madan Jay P. INNT Common Stock D 1,554,167
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,154,629
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,147,140
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,147,140
2018-02-08 3 Madan Jay P. INNT Common Stock D 1,554,167
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,147,140
2018-02-08 3 Madan Jay P. INNT Common Stock I 1,147,140
2017-11-21 2017-11-09 4 BARRE STEVEN C MSDI Common Stock A - Award D 10,000 50,000
2017-11-21 2017-11-09 4 CLARK JONATHAN P MSDI Common Stock A - Award D 25,000 275,000
2017-11-21 2017-11-09 4 Olert David Lewis MSDI Common Stock A - Award D 10,000 60,000
2017-07-13 2017-05-08 4 Olert David Lewis MSDI Common Stock A - Award D 10,000 50,000
2017-07-13 2017-07-11 4 BARRE STEVEN C MSDI Common Stock A - Award D 10,000 40,000
2017-07-13 2017-05-31 4 BARRE STEVEN C MSDI Common Stock A - Award D 15,000 30,000
2017-07-13 2017-07-11 4 MACHINIST ROBERT MSDI Common Stock A - Award D 10,000 35,000
2017-07-13 2017-05-31 4 MACHINIST ROBERT MSDI Common Stock A - Award D 10,000 25,000
2017-07-13 2017-07-11 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 10,000 35,000
2017-07-13 2017-05-31 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 10,000 25,000
2017-02-10 3 BROWNSELL STEPHEN R MSDI Common Stock D 270,000
2017-02-10 3 BROWNSELL STEPHEN R MSDI Common Stock D 270,000
2017-01-27 2017-01-24 4 MACHINIST ROBERT MSDI Common Stock A - Award D 5,000 15,000
2017-01-26 2017-01-24 4 BARRE STEVEN C MSDI Common Stock A - Award D 5,000 15,000
2017-01-26 2017-01-24 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 5,000 15,000
2017-01-26 2017-01-24 4 CLARK JONATHAN P MSDI Common Stock A - Award D 240,000 250,000
2017-01-25 2017-01-24 4 Olert David Lewis MSDI Common Stock A - Award D 15,000 40,000
2017-01-25 2017-01-24 4 MATEJKA MARC S MSDI Common Stock A - Award D 15,000 40,000
2016-11-18 2016-11-16 4 BARRE STEVEN C MSDI Common Stock A - Award D 10,000 10,000
2016-07-27 2016-07-07 4 CLARK JONATHAN P MSDI Common Stock A - Award D 10,000 10,000
2016-07-26 2016-07-07 4 Olert David Lewis MSDI Employee Stock Options (right to buy_ A - Award D 4.50 16,834 16,834
2016-07-26 2016-07-07 4 Olert David Lewis MSDI Common Stock A - Award D 25,000 25,000
2016-07-26 2016-07-07 4 TANDON VIVEK MSDI Employee Stock Options (right to buy) A - Award D 4.50 18,000 18,000
2016-07-26 2016-07-07 4 TANDON VIVEK MSDI Common Stock A - Award D 25,000 25,000
2016-07-26 2016-07-07 4 TANDON JAWAHAR See footnote 3. MSDI Warrants to Purchase Common Stock A - Award I 5.62 76,911 76,911
2016-07-26 2016-07-07 4 TANDON JAWAHAR MSDI Common Stock A - Award D 125,000 125,000
2016-07-20 2016-07-07 4 ORBAN JONATHAN S MSDI Common Stock A - Award D 10,000 10,000
2016-07-19 2016-07-07 4 MATEJKA MARC S MSDI Employee Stock Options (right to buy) A - Award D 4.50 18,000 18,000
2016-07-19 2016-07-07 4 MATEJKA MARC S MSDI Common Stock A - Award D 25,000 25,000
2016-07-13 2016-07-07 4 MACHINIST ROBERT MSDI Common Stock A - Award D 10,000 10,000
2016-07-13 2016-07-07 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 10,000 10,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2026 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Features
Explore
Help Center